Literature DB >> 19229233

Postmenopausal estrogen therapy: which route to take?

James A Simon1.   

Abstract

Mesh：

Year:  2009        PMID： 19229233     DOI： 10.1038/ncpendmet1073

Source DB:  PubMed          Journal:  Nat Clin Pract Endocrinol Metab        ISSN： 1745-8366


× No keyword cloud information.
  10 in total

1.  Markedly elevated levels of estrone sulfate after long-term oral, but not transdermal, administration of estradiol in postmenopausal women.

Authors:  C C Slater; H N Hodis; W J Mack; D Shoupe; R J Paulson; F Z Stanczyk
Journal:  Menopause       Date:  2001 May-Jun       Impact factor: 2.953

Review 2.  New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.

Authors:  Maria Grazia Modena; Piero Sismondi; Alfred O Mueck; Frédérique Kuttenn; Bruno de Lignières; Johan Verhaeghe; Jean Michel Foidart; Anne Caufriez; Andrea Riccardo Genazzani
Journal:  Maturitas       Date:  2005-09-16       Impact factor: 4.342

3.  Hormone therapy and risk of myocardial infarction: a national register study.

Authors:  Ellen Løkkegaard; Anne Helms Andreasen; Rikke Kart Jacobsen; Lars Hougaard Nielsen; Carsten Agger; Øjvind Lidegaard
Journal:  Eur Heart J       Date:  2008-09-30       Impact factor: 29.983

Review 4.  Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.

Authors:  Marc L'hermite; Tommaso Simoncini; Sarah Fuller; Andrea Riccardo Genazzani
Journal:  Maturitas       Date:  2008-09-05       Impact factor: 4.342

Review 5.  Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis.

Authors:  Marianne Canonico; Geneviève Plu-Bureau; Gordon D O Lowe; Pierre-Yves Scarabin
Journal:  BMJ       Date:  2008-05-20

Review 6.  Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women.

Authors:  S R Salpeter; J M E Walsh; T M Ormiston; E Greyber; N S Buckley; E E Salpeter
Journal:  Diabetes Obes Metab       Date:  2006-09       Impact factor: 6.577

7.  Increased need for thyroxine in women with hypothyroidism during estrogen therapy.

Authors:  B M Arafah
Journal:  N Engl J Med       Date:  2001-06-07       Impact factor: 91.245

8.  Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study.

Authors:  Agnès Fournier; Franco Berrino; Françoise Clavel-Chapelon
Journal:  Breast Cancer Res Treat       Date:  2007-02-27       Impact factor: 4.872

9.  Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study.

Authors:  Bette Liu; Valerie Beral; Angela Balkwill; Jane Green; Siân Sweetland; Gillian Reeves
Journal:  BMJ       Date:  2008-07-10

10.  The effects of transdermal and oral oestrogen replacement therapy on colorectal cancer risk in postmenopausal women.

Authors:  I Csizmadi; J-P Collet; A Benedetti; J-F Boivin; J A Hanley
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640
  10 in total
  1 in total

1.  Postmenopausal hormone therapy: risks versus benefits reassessed.

Authors:  James A Simon
Journal:  Nat Rev Endocrinol       Date:  2010-12       Impact factor: 43.330
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.